# CryoPort Inc. (CYRX)

Source: https://www.quantisnow.com/company/CYRX
Generated: 2026-11-15T15:40:54.758Z

- Ticker: CYRX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0001124524
- Website: cryoport.com

## About

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities are maintained throughout the shipping cycle; and Cryoport Express Advanced Therapy Shippers that provides verification processes to biopharma companies. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

## Latest CYRX news and filings

- 2026-11-12 23:30 UTC [SEC Form 4] [Chief Scientific Officer Sawicki Mark W sold $199,261 worth of shares (10,000 units at $19.93), decreasing direct ownership by 10% to 92,356 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-scientific-officer-sawicki-mark-w-sold-199261-worth-of-6789008)
- 2026-11-12 23:27 UTC [SEC Form 4] [Director Hancock Daniel M exercised 74,379 shares at a strike of $9.91 and sold $1,502,976 worth of shares (74,379 units at $20.21) (SEC Form 4)](https://www.quantisnow.com/insight/director-hancock-daniel-m-exercised-74379-shares-at-a-strike-6789000)
- 2026-11-05 22:08 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by CryoPort Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cryoport-inc-6777311)
- 2026-11-05 21:31 UTC [SEC Form 8-K] [CryoPort Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cryoport-inc-filed-sec-form-8-k-results-of-operations-and-6776957)
- 2026-11-05 21:05 UTC [Earnings] [Cryoport Reports Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/cryoport-reports-third-quarter-2026-financial-results-6776100)
- 2026-10-22 12:00 UTC [Earnings Date] [Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026](https://www.quantisnow.com/insight/cryoport-to-report-third-quarter-2026-financial-results-on-november-6754490)
- 2026-08-13 21:05 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by CryoPort Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-cryoport-inc-6681213)
- 2026-08-11 22:49 UTC [SEC Form 4] [President, CEO Shelton Jerrell sold $429,385 worth of shares (28,800 units at $14.91) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,201,814 units (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-shelton-jerrell-sold-429385-worth-of-shares-28800-6676637)
- 2026-08-06 21:03 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by CryoPort Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cryoport-inc-6669908)
- 2026-08-06 20:30 UTC [SEC Form 8-K] [CryoPort Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cryoport-inc-filed-sec-form-8-k-results-of-operations-and-6669570)
- 2026-08-06 20:05 UTC [Earnings Date] [Cryoport Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/cryoport-reports-second-quarter-2026-financial-results-6668809)
- 2026-07-23 12:00 UTC [Earnings Date] [Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026](https://www.quantisnow.com/insight/cryoport-to-report-second-quarter-2026-financial-results-on-august-6646332)
- 2026-06-25 12:00 UTC [Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs](https://www.quantisnow.com/insight/cryoports-integricell-cryopreservation-services-selected-by-verismo-therapeutics-to-support-6615168)
- 2026-06-23 11:51 UTC [SEC Form S-8] [SEC Form S-8 filed by CryoPort Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-cryoport-inc-6611841)
- 2026-06-22 21:21 UTC [SEC Form 15-12G filed by CryoPort Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-cryoport-inc-6611219)
- 2026-06-12 22:38 UTC [SEC Form 4] [Chief Digital and Tech Officer Zecchini Edward J exercised 35,000 shares at a strike of $4.80 and sold $507,563 worth of shares (35,000 units at $14.50) (SEC Form 4)](https://www.quantisnow.com/insight/chief-digital-and-tech-officer-zecchini-edward-j-exercised-35000-6601376)
- 2026-06-09 21:00 UTC [SEC Form 8-K] [CryoPort Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cryoport-inc-filed-sec-form-8-k-submission-of-matters-to-6595743)
- 2026-06-09 18:02 UTC [SEC Form 4] [Director Baddour Linda was granted 10,350 shares, increasing direct ownership by 18% to 68,099 units (SEC Form 4)](https://www.quantisnow.com/insight/director-baddour-linda-was-granted-10350-shares-increasing-direct-ownership-6595037)
- 2026-06-09 01:11 UTC [SEC Form 4] [Chief Financial Officer Stefanovich Robert sold $2,756,984 worth of shares (169,427 units at $16.27), decreasing direct ownership by 61% to 109,850 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-stefanovich-robert-sold-2756984-worth-of-shares-6594245)
- 2026-06-09 01:09 UTC [SEC Form 4] [Director Hancock Daniel M was granted 10,350 shares, increasing direct ownership by 18% to 69,052 units (SEC Form 4)](https://www.quantisnow.com/insight/director-hancock-daniel-m-was-granted-10350-shares-increasing-direct-6594243)
- 2026-06-09 01:07 UTC [SEC Form 4] [Director Hariri Robert J was granted 10,350 shares, increasing direct ownership by 20% to 61,625 units (SEC Form 4)](https://www.quantisnow.com/insight/director-hariri-robert-j-was-granted-10350-shares-increasing-direct-6594241)
- 2026-06-09 01:05 UTC [SEC Form 4] [Director Mandalam Ramkumar was granted 10,350 shares and sold $358,452 worth of shares (23,214 units at $15.44), decreasing direct ownership by 16% to 67,894 units (SEC Form 4)](https://www.quantisnow.com/insight/director-mandalam-ramkumar-was-granted-10350-shares-and-sold-358452-6594239)
- 2026-05-29 21:12 UTC [SEC Form SD filed by CryoPort Inc.](https://www.quantisnow.com/insight/sec-form-sd-filed-by-cryoport-inc-6579890)
- 2026-05-05 18:36 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by CryoPort Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cryoport-inc-6531588)
- 2026-05-04 20:30 UTC [SEC Form 8-K] [CryoPort Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cryoport-inc-filed-sec-form-8-k-results-of-operations-and-6529392)
- 2026-05-04 20:05 UTC [Earnings Date] [Cryoport Reports First Quarter 2026 Financial Results](https://www.quantisnow.com/insight/cryoport-reports-first-quarter-2026-financial-results-6528891)
- 2026-04-24 00:00 UTC [SEC Form 4] [President, CEO Shelton Jerrell exercised 104,007 shares at a strike of $1.87, increasing direct ownership by 9% to 1,230,614 units (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-shelton-jerrell-exercised-104007-shares-at-a-strike-6513316)
- 2026-04-22 20:31 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by CryoPort Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-cryoport-inc-6510689)
- 2026-04-22 20:30 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by CryoPort Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-cryoport-inc-6510641)
- 2026-04-20 20:05 UTC [Earnings Date] [Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026](https://www.quantisnow.com/insight/cryoport-to-report-first-quarter-2026-financial-results-on-may-6506630)
- 2026-04-08 22:32 UTC [SEC Form 4] [SEC Form 4 filed by Shelton Jerrell](https://www.quantisnow.com/insight/sec-form-4-filed-by-shelton-jerrell-6493464)
- 2026-03-26 21:41 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by CryoPort Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-cryoport-inc-6471973)
- 2026-03-26 00:01 UTC [SEC Form 4] [SEC Form 4 filed by Stefanovich Robert](https://www.quantisnow.com/insight/sec-form-4-filed-by-stefanovich-robert-6469598)
- 2026-03-26 00:00 UTC [SEC Form 4] [SEC Form 4 filed by Shelton Jerrell](https://www.quantisnow.com/insight/sec-form-4-filed-by-shelton-jerrell-6469596)
- 2026-03-26 00:00 UTC [SEC Form 4] [SEC Form 4 filed by Sawicki Mark W](https://www.quantisnow.com/insight/sec-form-4-filed-by-sawicki-mark-w-6469592)
- 2026-03-18 00:01 UTC [SEC Form 4] [Officer Zecchini Edward J was granted 21,322 shares and sold $16,112 worth of shares (2,014 units at $8.00), increasing direct ownership by 21% to 109,719 units (SEC Form 4)](https://www.quantisnow.com/insight/officer-zecchini-edward-j-was-granted-21322-shares-and-sold-6454128)
- 2026-03-18 00:00 UTC [SEC Form 4] [President, CEO Shelton Jerrell sold $63,344 worth of shares (7,918 units at $8.00), decreasing direct ownership by 0.75% to 1,054,501 units (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-shelton-jerrell-sold-63344-worth-of-shares-7918-6454127)
- 2026-03-18 00:00 UTC [SEC Form 4] [Chief Scientific Officer Sawicki Mark W was granted 22,845 shares and sold $25,880 worth of shares (3,235 units at $8.00), increasing direct ownership by 23% to 103,697 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-scientific-officer-sawicki-mark-w-was-granted-22845-shares-6454118)
- 2026-03-17 01:35 UTC [SEC Form 4] [Chief Financial Officer Stefanovich Robert exercised 87,188 shares at a strike of $1.87, sold $322,330 worth of shares (41,443 units at $7.78) and was granted 27,413 shares, increasing direct ownership by 35% to 280,371 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-stefanovich-robert-exercised-87188-shares-at-a-6450739)
- 2026-03-12 20:17 UTC [SEC Form 144] [SEC Form 144 filed by CryoPort Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-cryoport-inc-6444695)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CYRX
- Earnings history: https://www.quantisnow.com/earnings/CYRX
- Dividend history: https://www.quantisnow.com/dividends/CYRX
- Insider transactions: https://www.quantisnow.com/insiders/CYRX
- Options chain: https://www.quantisnow.com/options/CYRX
- SEC 8-K filings only: https://www.quantisnow.com/company/CYRX/8-k
- RSS and alerts for CYRX: https://www.quantisnow.com/docs/rss-feeds.md